Neutropenia
173
13
14
114
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
30 trials with published results (17%)
Research Maturity
114 completed trials (66% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.2%
9 terminated out of 173 trials
92.7%
+6.2% vs benchmark
27%
47 trials in Phase 3/4
26%
30 of 114 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 114 completed trials
Clinical Trials (173)
Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
Luspatercept for Clonal Cytopenias of Uncertain Significance
Predictive Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriaceae
Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection
Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
Neutropenia With TNF-α Inhibitors
PC001- A Study to Evaluate the Usability of PointCheck
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis
A Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders
Letermovir Use in Heart Transplant Recipients
Serial Blood Count Study
Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)
A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients
Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant
Study to Compare the Efficacy and Safety of F-627 and GRAN®
Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
Breath Analysis for the Detection of Invasive Fungal Infections
The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease